A naukri.com initiative
SiliconCanals
3w
202
Image Credit: SiliconCanals
Cedars-Sinai launches €43.4M Coronet Ventures Netherlands Fund to back Dutch health tech startups
- Cedars-Sinai Technology Ventures launches Coronet Ventures Netherlands Fund to support Dutch health tech startups.
- The fund aims to back early-stage health and life sciences startups in the Netherlands.
- James D. Laur highlights the goal of accelerating clinical translation and bringing breakthrough technologies to patients faster.
- Cedars-Sinai, based in Los Angeles, focuses on clinical care and research in areas like heart disease, cancer, and brain disorders.
- Coronet Ventures Netherlands will invest €43.4M over the next decade to support Dutch startups in biomedical and health tech solutions.
- Startups funded by the new fund will have access to Cedars-Sinai's clinical data environment and commercialization support.
- The initiative is part of Cedars-Sinai Technology Ventures to connect researchers, entrepreneurs, and investors for impactful healthcare solutions.
- Coronet Ventures Netherlands joins Cedars-Sinai's international portfolio alongside Coronet Ventures U.S. and Coronet Ventures Singapore.
- The partnership aims to facilitate a platform with deep clinical validation and support for companies to scale quickly into the U.S.
- The new venture fund extends the existing collaboration between Cedars-Sinai and Dutch innovators.
- HealthPlus.ai, an Amsterdam-based startup, predicts infection risk using health records and AI.
- Syntho, a company from Amsterdam, uses AI to generate synthetic healthcare data for medical researchers.
- Syntho has completed a pilot program with Cedars-Sinai and is discussing further collaboration with the organization's AI Lab.
Read Full Article
12 Likes
For uninterrupted reading, download the app